SCHEMBL6447422

SCHEMBL6447422

CC(C)(C)OC(=O)NC(Cc1ccccc1)C1OC1C(Cc1ccccc1)NC(=O)OC(C)(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.56
▸ CTSS P25774 4/20 0.54
▸ CTSK P43235 3/20 0.54
▸ CTSL P07711 1/20 0.54
▸ CTSB P07858 1/20 0.54
▸ REN P00797 2/20 0.52
▸ ACE P12821 1/20 0.52
▸ ALDH1A1 P00352 2/20 0.49
▸ MEN1 O00255 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ PKM P14618 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ XBP1 P17861 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6446223 0.93 ATM (0.50) ATMCTSSCTSKCTSLCTSB
SCHEMBL6449177 0.91 REN (0.53) ATMCTSSCTSKCTSLCTSB
SCHEMBL7332650 0.86 REN (0.49) ATMCTSSCTSKCTSLCTSB
SCHEMBL14194515 0.85 ATM (0.47) ATMCTSSCTSKCTSLCTSB
SCHEMBL4810353 0.85 ATM (0.47) ATMCTSSCTSKCTSLCTSB
SCHEMBL1104909 0.84 ATM (0.54) ATMCTSSCTSKCTSLCTSB
SCHEMBL7438571 0.84 ATM (0.54) ATMCTSSCTSKCTSLCTSB
SCHEMBL5865405 0.84 ATM (0.54) ATMCTSSCTSKCTSLCTSB
SCHEMBL639229 0.84 ATM (0.54) ATMCTSSCTSKCTSLCTSB
SCHEMBL496136 0.84 ATM (0.54) ATMCTSSCTSKCTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 — — EP claimed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 — — US claimed
EP-0839798-B1 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LAB (US) 2005-08-17 — — EP disclosed
EP-0839798-A3 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-09-09 — — EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 — — EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 — — EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 — — US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 — — US disclosed
US-5142056-A Human immunodeficiency virus protease inhibitor ABBOTT LABORATORIES (US) 1992-08-25 — — US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 — — EP disclosed
Send feedback